A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and ...

Longer-term trial results show Voranigo may help control grade 2 IDH-mutated glioma after surgery for those who can delay ...

Androgen receptor pathway inhibitors (ARPIs) in combination with androgen deprivation therapy (ADT) represent the foundation ...

Vorasidenib significantly improved median progression-free survival and time to next intervention in IDH-mutant grade 2 ...

"These longer-term results from the INDIGO trial build upon VORANIGO's previously demonstrated clinical benefits and ...

While AI advancements like 3D tumor auto-segmentation and radiation therapy planning have been FDA-approved for adult oncology, pediatric standards were lacking. The AI-RAPNO policy and its companion ...

On Oct 8, 2025, a new law was introduced in British Columbia, Canada, that, if passed, will take action against e-cigarette ...

News involving the treatment of multiple myeloma this year was highlighted by talk of a potential cure with a single infusion ...

While most of what the FDA laid out in a recent draft guidance on the assessment of overall survival in oncology clinical ...

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of ...

Tanzania has launched its first undergraduate and postgraduate programmes in medical physics, with support from the IAEA, to strengthen the country’s capacity in cancer care through high-quality ...

An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising ...